Summarize Written Text

A long-running cohort study following over 6,000 adults across two decades has added nuance to public health messaging about moderate alcohol consumption, an area where earlier observational research had suggested modest cardiovascular benefits. Participants, recruited between ages 40 and 65 and free of diagnosed cardiovascular disease at enrollment, were grouped by self-reported drinking patterns and followed through medical records, biannual health screenings, and cause-of-death registries where applicable. Consistent with some earlier findings, the study found that participants who reported light to moderate drinking, defined as up to one standard drink daily, showed a slightly lower incidence of coronary events than lifetime abstainers during the first decade of follow-up. However, when researchers reanalyzed the abstainer group and separated out individuals who had stopped drinking due to prior health problems, a distinction earlier studies had often failed to make, the apparent protective effect of moderate drinking shrank considerably and lost statistical significance for participants under age 55. The revised analysis also found that the cardiovascular benefit, where it persisted in older participants, was accompanied by a modestly elevated risk of several cancers, including breast and colorectal cancer, that increased in rough proportion to reported alcohol intake even at levels previously considered moderate. When researchers combined all-cause mortality data rather than isolating cardiovascular outcomes alone, no drinking category showed a statistically significant survival advantage over non-drinking once the reclassified abstainer group was used as the comparison baseline. The study's authors emphasize that their findings do not support recommending alcohol consumption for health benefits, and suggest that previous guidance suggesting protective effects may have been distorted by the inclusion of former drinkers, who quit due to illness, within the abstainer comparison group, artificially depressing that group's apparent health outcomes.